EFFECT OF FOOD ON THE PHARMACOKINETICS OF ANAPLASTIC LYMPHOMA KINASE (ALK) INHIBITOR CERITINIB IN HEALTHY SUBJECTS.

被引：0
|
作者：
Lau, Y. [1 ]
Lin, T. [1 ]
Song, D. [1 ]
Gu, J. [1 ]
Yu, R. [1 ]
Joe, A. [1 ]
机构：
[1] Novartis Pharmaceut, E Hanover, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2015年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII-043
引用
收藏
页码：S71 / S72
页数：2
相关论文
共 50 条
  • [21] AN OPEN-LABEL STUDY TO ASSESS THE EFFECT OF FOOD ON THE PHARMACOKINETICS OF SOTORASIB IN HEALTHY SUBJECTS.
    Cardona, P.
    Hutton, S.
    Purkis, J.
    Mather, O.
    Dutta, S.
    Houk, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S12 - S12
  • [22] Effect of rifampin on the pharmacokinetics of rosiglitazone in Korean healthy subjects.
    Park, J
    Kim, K
    Jung, W
    Kim, S
    Shin, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P34 - P34
  • [23] Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone in healthy subjects.
    Lebrun-Vignes, B
    Chosidow, O
    Diquet, B
    Levron, JC
    Herson, S
    Corbrion-Archer, V
    Puech, AJ
    Warot, D
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 683 - 683
  • [24] Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects.
    Lee, Y
    Orlowski, LH
    Michiels, N
    Petty, KJ
    Goldberg, MR
    Dru, J
    Chavez-Eng, CM
    Constanzer, M
    Murphy, G
    Gottesdiener, K
    Hesney, M
    Feuring, M
    Wehling, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 73 (02) : P66 - P66
  • [25] EFFECT OF ACTIVATED CHARCOAL ON THE PHARMACOKINETICS OF APIXABAN IN HEALTHY SUBJECTS.
    Wang, X.
    Tirucherai, G.
    Pannacciulli, N.
    Wang, J.
    Elsrougy, A.
    Teslenko, V.
    Chang, M.
    Zhang, D.
    Frost, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 : S41 - S41
  • [26] The Association between the Percentage of Anaplastic Lymphoma Kinase(ALK)-Positive Cells and Efficacy of ALK Inhibitor
    Tanaka, Tae
    Yoshioka, Hiroshige
    Haratani, Koji
    Hayashi, Hidetoshi
    Okamoto, Kunio
    Kaneda, Toshihiko
    Yokoyama, Toshihide
    Takeda, Masayuki
    Kaneda, Hiroyasu
    Nakagawa, Kazuhiko
    Ishida, Tadashi
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1162 - S1162
  • [27] Atypical Carcinoid Tumor with Anaplastic Lymphoma Kinase (ALK) Rearrangement Successfully Treated by an ALK Inhibitor
    Nakajima, Masayuki
    Uchiyama, Naoki
    Shigemasa, Rie
    Matsumura, Takeshi
    Matsuoka, Ryota
    Nomura, Akihiro
    INTERNAL MEDICINE, 2016, 55 (21) : 3151 - 3153
  • [28] The effect of food on the pharmacokinetics of Sutetinib maleate capsule, an irreversible EGFR tyrosine kinase inhibitor, in healthy Chinese subjects
    Cao, Bei
    Ma, Tingting
    Zhang, Yuqiang
    Huang, Lei
    Lin, Hui
    Jiang, Huanhuan
    Zhao, Yu
    Geng, Yan
    Yang, Yuanxun
    Cao, Sumin
    Li, Juan
    INVESTIGATIONAL NEW DRUGS, 2024, 42 (03) : 289 - 298
  • [29] EFFECT OF BODY WEIGHT ON THE PHARMACOKINETICS OF APIXABAN, AN ORAL DIRECT FACTOR Xa INHIBITOR, IN HEALTHY SUBJECTS.
    Upreti, Vijay V.
    Wang, Jessie
    Barrett, Yuchen
    Boyd, Rebecca
    Bui, Anh
    Li, Tong
    LaCreta, Frank P.
    Frost, Charles E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1060 - 1060
  • [30] Rimonabant pharmacokinetics in healthy and obese subjects.
    Turpault, S
    Kanamaluru, V
    Lockwood, GF
    Bonnet, D
    Newton, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2006, 79 (02) : P50 - P50
12345